Ipratropium - from COPD to Parkinson's disease?

Nissen, Lisa M. (2010) Ipratropium - from COPD to Parkinson's disease?. Australian Pharmacist, 29 10: 842-842.

Attached Files (Some files may be inaccessible until you login with your UQ eSpace credentials)
Name Description MIMEType Size Downloads
Author Nissen, Lisa M.
Title Ipratropium - from COPD to Parkinson's disease?
Journal name Australian Pharmacist   Check publisher's open access policy
ISSN 0728-4632
Publication date 2010-10
Sub-type Article (original research)
Volume 29
Issue 10
Start page 842
End page 842
Total pages 1
Place of publication Australia
Publisher Pharmaceutical Society of Australia
Collection year 2011
Language eng
Abstract Parkinson’s disease (PD) is a progressive condition of the central nervous system affecting movement. PD is a debilitating condition which affects around 50,000 Australians at any one time, with the prevalence in those over 65 years estimated at about 1%. PD usually begins between the ages of 40–70 with the average age of onset being 61.6 years. Interestingly only 5–10% of patients are diagnosed before the age of 40.
Q-Index Code C1
Q-Index Status Confirmed Code
Institutional Status UQ

Document type: Journal Article
Sub-type: Article (original research)
Collections: Official 2011 Collection
School of Pharmacy Publications
Version Filter Type
Citation counts: Google Scholar Search Google Scholar
Created: Mon, 07 Mar 2011, 11:20:44 EST by Charna Kovacevic on behalf of School of Pharmacy